Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery.
about
Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interactionExpression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura.OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts.Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individualsCD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis.Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infectionHuman immunodeficiency virus (HIV) type 1 Vpu induces the expression of CD40 in endothelial cells and regulates HIV-induced adhesion of B-lymphoma cells.Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.Decreased CD95 expression on naive T cells from HIV-infected persons undergoing highly active anti-retroviral therapy (HAART) and the influence of IL-2 low dose administration. Irhan Study Group.
P2860
Q28731004-C6305D75-5B92-4C53-BD52-651671CC18E9Q33424522-BEEF9B3B-9951-4B48-9F2B-D1841D4A5B0EQ33844046-0D54E55D-A343-4CFD-A0E8-E4F7713C5D78Q33943382-A23EBFA3-7B04-4974-BDF8-3CF2901CD9E7Q35022773-E8A663DE-C0FB-41DA-9AF5-4724D8DA3180Q35747327-AD74BF2F-DC71-479F-A50E-16AE1C4CB8F3Q35946434-43E02BC4-41AA-46A0-8081-C64C0F88CF06Q37422645-75E8D2B3-D7D7-45E8-95DC-8AA44E059E59Q37727208-9BB4C6B9-19B3-40FD-9A3C-48F0B8A16A78Q42212835-5154423E-9254-4E0D-8BE1-30F53B59BAA3Q52027267-57AE06C8-6820-4D13-B914-8C336F1B9D20
P2860
Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Early reduction of the over-ex ...... affic and functional recovery.
@en
Early reduction of the over-ex ...... affic and functional recovery.
@nl
type
label
Early reduction of the over-ex ...... affic and functional recovery.
@en
Early reduction of the over-ex ...... affic and functional recovery.
@nl
prefLabel
Early reduction of the over-ex ...... affic and functional recovery.
@en
Early reduction of the over-ex ...... affic and functional recovery.
@nl
P2860
P50
P1476
Early reduction of the over-ex ...... raffic and functional recovery
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.1999.00872.X
P577
1999-05-01T00:00:00Z